SCHEMBL30565233

SCHEMBL30565233

Cc1ccc(Nc2ncc(C)c(Nc3cccc(S(=O)(=O)NC(C)(C)C)c3)n2)cc1S(N)(=O)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 12/20 0.68
▸ JAK3 P52333 11/20 0.68
▸ JAK2 O60674 7/20 0.68
▸ BRD4 O60885 7/20 0.68
▸ RET P07949 3/20 0.68
▸ WEE1 P30291 3/20 0.68
▸ FLT3 P36888 3/20 0.68
▸ ALK Q9UM73 3/20 0.68
▸ BRDT Q58F21 2/20 0.68
▸ BUB1B O60566 1/20 0.68
▸ BRD2 P25440 1/20 0.68
▸ BRD3 Q15059 1/20 0.68
▸ HDAC1 Q13547 4/20 0.65
▸ TYK2 P29597 4/20 0.63
▸ SYK P43405 3/20 0.63
▸ EGFR P00533 3/20 0.63
▸ BTK Q06187 3/20 0.63
▸ PLK4 O00444 2/20 0.63
▸ CHEK1 O14757 2/20 0.63
▸ AURKA O14965 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25382924 1.00 JAK1 (0.68) JAK1JAK3JAK2BRD4RET
SCHEMBL30565204 0.92 BRD4 (0.74) JAK1JAK3JAK2BRD4RET
SCHEMBL30565206 0.92 BRD4 (0.74) JAK1JAK3JAK2BRD4RET
SCHEMBL25382998 0.92 BRD4 (0.74) JAK1JAK3JAK2BRD4RET
SCHEMBL31163062 0.91 JAK1 (0.76) JAK1JAK3JAK2BRD4RET
SCHEMBL13031046 0.89 BRD4 (0.74) JAK1JAK3JAK2BRD4RET
SCHEMBL13031088 0.89 BRD4 (0.73) JAK1JAK3JAK2BRD4RET
SCHEMBL13031062 0.87 BRD4 (0.71) JAK1JAK3JAK2BRD4RET
SCHEMBL20778927 0.87 JAK2 (0.74) JAK1JAK3JAK2BRD4RET
SCHEMBL13031073 0.86 BRD4 (0.67) JAK1JAK3JAK2BRD4RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
EP-4486348-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2025-01-08 — — EP disclosed
CN-118804751-A New compounds and treatment of renal cell carcinoma 巴什生物技术公司 2024-10-18 — — CN disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
WO-2023166153-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC (US) 2023-09-07 — — WO disclosed
Send feedback